Results 251 to 260 of about 7,045,458 (313)

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Unveiling the role of aldosterone in metabolic dysfunction-associated steatotic liver disease. [PDF]

open access: yesRev Endocr Metab Disord
Hernández-Rubio A   +4 more
europepmc   +1 more source

Pharmacologic management of metabolic and alcohol-associated liver disease. [PDF]

open access: yesMetab Target Organ Damage
Pagadala M, Jalil S, Dunn N, Singal AK.
europepmc   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults With Acromegaly: A Meta-Analysis of Observational Studies. [PDF]

open access: yesDiabetes Metab Res Rev
Mantovani A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy